𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura

✍ Scribed by Chikara Ogimi; Nazuna Honma; Risa Tanaka; Tsutomu Oh-ishi

Book ID
113057873
Publisher
Springer
Year
2011
Tongue
English
Weight
206 KB
Volume
22
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Continuous, low-dose therapy with interf
Continuous, low-dose therapy with interferon-Ξ± for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura
✍ Donald W. Northfelt; Lawrence D. Kaplan; Donald I. Abrams πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 1 views

## Abstract A patient with HIV‐related immune thrombocytopenic purpura (HIV‐ITP) had a rapid rise in platelet count when treated with interferon‐α2b, 3 million units three times weekly. There were no significant toxicities with therapy. His platelet count fell to pretreatment levels when therapy wa

Rituximab therapy for thrombotic thrombo
Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders
✍ James N. George; Robert D. Woodson; Joseph E. Kiss; Kiarash Kojouri; Sara K. Ves πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract The rationale for immunosuppressive therapy of thrombotic thrombocytopenic purpura (TTP) was established by observations that TTP may be caused by autoantibodies to ADAMTS13. Patients with high‐titer autoantibodies to ADAMTS13 may have a higher mortality, and survivors may require prolo